InspireMD (NYSE:NSPR) Share Price Crosses Above 50-Day Moving Average – Time to Sell?

Shares of InspireMD, Inc. (NYSE:NSPR) passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $0.65 and traded as high as $0.6757. InspireMD shares last traded at $0.6579, with a volume of 530,399 shares changing hands.

InspireMD Price Performance

The firm has a market capitalization of $30.59 million, a PE ratio of -0.88 and a beta of 0.92. The firm has a 50-day simple moving average of $0.65 and a 200-day simple moving average of $1.06.

Hedge Funds Weigh In On InspireMD

Several institutional investors have recently made changes to their positions in NSPR. Nantahala Capital Management LLC purchased a new position in shares of InspireMD in the second quarter worth approximately $2,363,876. Parkman Healthcare Partners LLC bought a new stake in InspireMD during the second quarter valued at approximately $1,692,000. BlackRock Inc. bought a new stake in InspireMD during the second quarter valued at approximately $86,000. Finally, Renaissance Technologies LLC bought a new stake in InspireMD during the first quarter valued at approximately $29,000. Institutional investors own 44.78% of the company’s stock.

About InspireMD

InspireMD, Inc is a medical device company focused on developing and commercializing products for the treatment of carotid artery disease and the prevention of stroke. Its technology is designed to support minimally invasive procedures that restore blood flow in narrowed or blocked arteries while helping to reduce the risk of embolic debris reaching the brain.

The company’s principal product is the CGuard carotid embolic prevention system, which combines a self-expanding carotid stent with a proprietary microNet mesh intended to trap plaque and other debris against the arterial wall during and after carotid artery stenting.